NDC 50090-6982-01 - Levothyroxine Sodium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-6982
- Requested NDC
- 50090-6982-01
- Package NDCs from labels
- 50090-6982-1, 50090-6982-0, 50090-6982-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2026-01-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Levothyroxine Sodium - A-S Medication Solutions | A-S Medication Solutions | 2026-01-14 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-6982-0 | Levothyroxine Sodium | 30 in 1 BOTTLE | TABLET | 30 | 9 | |
| 50090-6982-1 | Levothyroxine Sodium | 90 in 1 BOTTLE | TABLET | 90 | 9 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-6982 | LEVOTHYROXINE SODIUM TABLET [A-S MEDICATION SOLUTIONS] | 7 | Current NDC, 2 package rows | 20231229_e2291336-1188-48f4-af52-d12ac892f80f.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-6982-0 | EA - Each | 50090-6982 | 532ca8c0-7614-4d20-a2b6-8a6b21a30b36 | 1 | 2024-02-14 |
| 50090-6982-1 | EA - Each | 50090-6982 | 6f035a2b-177b-4987-a1a4-475d43b62ea0 | 1 | 2024-02-14 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| levothyroxine sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals, Inc. | 4e6dce46-cbf5-4353-9d0c-36b6f857197a | 2026-01-13 | Boxed warning, Warnings, Adverse reactions | 966225 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Lannett Company, Inc | a8db0f7d-8863-9309-e053-2995a90a284a | 2026-01-08 | Boxed warning, Warnings, Adverse reactions | 966248 892251 966222 966270 892246 966221 892255 966224 966249 966220 966225 966253 9J765S329G |
| Sanar Baking Soda 8oz 100% pure | SODIUM BICARBONATE | Evi Labs | 47e7f801-3176-288c-e063-6394a90abef4 | 2026-01-08 | Warnings | 8MDF5V39QO |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | NuCare Pharmaceuticals, Inc. | 3d737f79-7fc9-4221-e063-6394a90ac9aa | 2026-01-07 | Boxed warning, Warnings, Adverse reactions | 966222 9J765S329G |
| DR. SANA BICARBONATO DE SODIO 4 Fl oz and 6 Floz | SODIUM BICARBONATE | Evi Labs | 47330d09-7db1-254d-e063-6294a90ae7de | 2026-01-07 | Warnings | 8MDF5V39QO |
| DE LA CRUZ SODIUM BICARBONATE ANTACID | SODIUM BICARBONATE | DLC Laboratories, Inc. | fc469943-9749-45ee-93f7-90fdbcdc7215 | 2026-01-07 | Warnings | 8MDF5V39QO |
| De La Cruz Desempacho | SODIUM BICARBONATE | DLC LABORATORIES, INC. | 741e105a-3ed2-4fc7-ab06-273e515a2d16 | 2026-01-07 | Warnings | 8MDF5V39QO |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | c968836a-f94c-4d13-e053-2995a90a8df5 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 966248 966222 966270 966221 966224 966225 966253 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | db10e666-6204-56cc-e053-2995a90a9e08 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 966248 9J765S329G |
| levothyroxine sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | db5dd9d2-4f96-25d0-e053-2995a90af9dc | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 966249 9J765S329G |
| levothyroxine sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | c9f4923e-5625-1d4f-e053-2a95a90aabc9 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 966221 9J765S329G |
| levothyroxine sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | db89c58f-9dd0-b6d6-e053-2a95a90ae2e7 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 966225 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | d9cb3417-e8cb-13f8-e053-2a95a90a294b | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | ANDA209713 966253 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | ca4634a5-d8d7-48a4-e053-2995a90a0cd4 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | ANDA209713 966249 966225 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | dac0af5d-622c-e18c-e053-2995a90a5739 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | ANDA209713 966270 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | f317a597-4644-746a-e053-2995a90a807f | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | ANDA209713 966224 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | e0503b8c-7eb7-269e-e053-2995a90a1bca | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | ANDA209713 966220 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | e08c2af4-c20a-3176-e053-2a95a90a1aa9 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | ANDA209713 966222 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | e3d949ce-731b-6dfe-e053-2a95a90a0074 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | ANDA209713 966248 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | f31b5d54-7536-4290-e053-2a95a90ac235 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 966249 9J765S329G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.